SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-042255
Filing Date
2023-04-05
Accepted
2023-04-05 17:26:41
Documents
13
Period of Report
2023-04-05
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2311853d1_8k.htm   iXBRL 8-K 39081
  Complete submission text file 0001104659-23-042255.txt   276165

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pmgm-20230405.xsd EX-101.SCH 4070
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmgm-20230405_def.xml EX-101.DEF 27972
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmgm-20230405_lab.xml EX-101.LAB 39560
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmgm-20230405_pre.xml EX-101.PRE 26590
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2311853d1_8k_htm.xml XML 7158
Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 23803595
SIC: 2834 Pharmaceutical Preparations